R&D Trends

Nodality, Pfizer form multi-year collaboration on autoimmune disease

Thursday, August 9, 2012 02:16 PM

Nodality, a San Francisco-based personalized medicine biotech, has formed a strategic collaboration to provide proprietary single cell network profiling (SCNP) technology as a tool for the development of Pfizer compounds.

More... »

NHLBI funds second phase of COPDGene project

Thursday, August 9, 2012 10:47 AM

The National Heart, Lung, and Blood Institute (NHLBI)has decided to fund the second phase (2012-2017) of the COPDGene project through R01 grants to National Jewish Health and the Brigham and Women’s Hospital.

More... »

Prevention trial studies population 100% genetically predisposed to early-onset Alzheimer’s

Monday, August 6, 2012 07:00 AM

For the first time ever, an experimental drug is being tested to determine whether it can prevent Alzheimer’s disease in a population that has a 100% genetic predisposition for early onset of the disease. The study, to start next year, will be one of only a few being conducted to test prevention treatments for a genetically predestined disease.

More... »

Gilead collaborates with Indian partners to reduce costs, improve availability of antiretroviral therapy

Thursday, August 2, 2012 02:44 PM

Pharmaceutical companies Gilead Sciences, Mylan Laboratories, Ranbaxy Laboratories and Strides Arcolab have entered into agreements to collaborate on promoting access to high-quality, low-cost generic versions of Gilead's HIV medicine emtricitabine (FTC) in developing countries, including single tablet regimens containing emtricitabine and fixed-dose combinations of emtricitabine co-formulated with other Gilead HIV medicines.

More... »

New York Genome Center launches innovation center

Thursday, August 2, 2012 11:42 AM

New York Genome Center (NYGC), a non-profit engaged in a cooperative effort to transform medical research and clinical care, has launched its innovation center, which will provide access to new sequencing technologies and foster collaboration among NYGC’s institutional founding members (IFMs) and technology collaborators.

More... »

Rejected Alzheimer's drug shows new potential

Wednesday, August 1, 2012 11:42 AM

An international team of scientists led by researchers at Mount Sinai School of Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer's disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer's disease. The findings, published July 31, 2012, in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients with early stages of the disease.

More... »

BMS Foundation marks World Hepatitis Day with new grants

Friday, July 27, 2012 11:22 AM

The Bristol-Myers Squibb Foundation has awarded four new grants totaling $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatitis C (HCV) in China and India as part of its Delivering Hope program.

More... »

NEA closes 14th fund with $2.6B committed capital

Wednesday, July 25, 2012 02:18 PM

New Enterprise Associates (NEA), a global venture capital firm that heavily invests in biopharma, healthcare services and medical device sectors, has officially closed its 14th fund with $2.6 billion in total committed capital. The fund, one of the largest venture funds ever raised, brings NEA's total committed capital to more than $13 billion across all funds.

More... »

AHAF awards 21 grants for promising vision research

Wednesday, July 25, 2012 11:48 AM

The American Health Assistance Foundation (AHAF), a nonprofit organization that funds breakthrough research on age-related vision diseases, has awarded 21 new grants totaling $2.1 million to scientists worldwide who are studying glaucoma and age-related macular degeneration (AMD).

More... »

Sanofi launches Collaborate Activate Innovation Challenge

Wednesday, July 25, 2012 10:22 AM

Sanofi US has launched the Collaborate Activate Innovation Challenge, which will award a total of $500,000 to teams of patient advocacy groups or medical professional associations who deliver novel approaches to better engage patients in their own health.

More... »